Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Chengxin Lü"'
Publikováno v:
Bulletin of Environmental Contamination and Toxicology. 110
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ea9880bafe3680a80a876bea6d1c927
https://doi.org/10.1007/s00128-022-03685-2
https://doi.org/10.1007/s00128-022-03685-2
Autor:
Jing Ni, Jian Hong, Xinglin Liang, Jifei Dai, Zhangbiao Long, ChengXin Luan, Mingzhen Yang, Qingsheng Li
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 8, Iss 7, Pp 102578- (2024)
Background: Thrombocytopenia after allogeneic hematopoietic cell transplantation is a challenging clinical problem. Recombinant human thrombopoietin (rhTPO) and thrombopoietin receptor agonists are increasingly used in posttransplant thrombocytopenia
Externí odkaz:
https://doaj.org/article/5087904f3c7b4959a969cd73617c7de9
Publikováno v:
ACS Sustainable Chemistry & Engineering. 8:12626-12636
Graphite and pyrolytic biochar are two electrically active but functionally distinct carbon materials that have been widely used to enhance methanogenic performance of anaerobic digestion (AD) of w...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::95c06b6266235308271d029392917026
https://doi.org/10.1021/acssuschemeng.0c04109
https://doi.org/10.1021/acssuschemeng.0c04109
Autor:
Chengxin Luan, Haixia Wang, Junjie Zhou, Zhangbiao Long, Xin Chen, Xiaowen Chen, Jing Ni, Zhengqi Huang, Ruixiang Xia, Jian Ge
Publikováno v:
Biomedical Technology, Vol 3, Iss , Pp 59-65 (2023)
Background: Tocilizumab is a well-practiced strategy to manage cytokine release syndrome (CRS) after chimeric antigen receptor T cell (CAR-T) therapy. However, varied efficiency in CRS mitigation by tocilizumab has been reported to highlight affectin
Externí odkaz:
https://doaj.org/article/318c40d0a0ac4162bd72a6440006f514
Autor:
Chengxin Luo, Xiangtao Huang, Ling Wei, Guixian Wu, Yarui Huang, Yaqun Ding, Zhen Huang, Jieping Chen, Xi Li, Yunding Zou, Shuangnian Xu
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
ObjectiveSteroids-refractory (SR) acute graft-versus-host disease (aGVHD) is a life-threatening condition in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT), but the optimal second-line therapy still has not been es
Externí odkaz:
https://doaj.org/article/e66f50146f0d4e6192233a60304994ac
Autor:
Chengxin Luo, Guixian Wu, Xiangtao Huang, Yali Zhang, Yanni Ma, Yarui Huang, Zhen Huang, Hui Li, Yu Hou, Jieping Chen, Xi Li, Shuangnian Xu
Publikováno v:
Stem Cell Research & Therapy, Vol 13, Iss 1, Pp 1-19 (2022)
Abstract Background Efficient mobilization of hematopoietic stem cells (HSCs) from bone marrow niche into circulation is the key to successful collection and transplantation in patients with hematological malignancies. The efficacy of various HSCs mo
Externí odkaz:
https://doaj.org/article/fb75744253b54d189ed38f745d63700b
Autor:
Yujing Wu, Aijun Zhang, Wensheng Chen, Qianling Xin, Wenwen Pan, Xiaoxi Hu, Tao Li, Hengshi Chen, Jing Zhang, Chengxin Luan, Jian Ge, Wei Wei
Publikováno v:
Pharmacological Research, Vol 189, Iss , Pp 106686- (2023)
T-cell acute lymphoblastic leukemia (T-ALL) has a poor prognosis as a result of severe immunosuppression and rapid tumor progression with resistance to conventional chemotherapy. Excessive IgD may play a role in T cell activation via IgD Fc receptor
Externí odkaz:
https://doaj.org/article/6592eae1af6c4e42871e3ebe1e03dfa3
Autor:
Yali Zhang, Yanni Ma, Guixian Wu, Mingling Xie, Chengxin Luo, Xiangtao Huang, Feng Tian, Jieping Chen, Xi Li
Publikováno v:
Cell Death Discovery, Vol 7, Iss 1, Pp 1-10 (2021)
Abstract Mantle cell lymphoma (MCL) is highly aggressive and its treatment remains challenging, understanding its pathogenesis is critical for future targeted therapy. SUMO specific proteases 1 (SENP1) is an important protein that regulates the balan
Externí odkaz:
https://doaj.org/article/979a48d7da584b8d910f71830feffd07
Autor:
Chengxin Luo, Li Wang, Guixian Wu, Xiangtao Huang, Yali Zhang, Yanni Ma, Mingling Xie, Yanni Sun, Yarui Huang, Zhen Huang, Qiuyue Song, Hui Li, Yu Hou, Xi Li, Shuangnian Xu, Jieping Chen
Publikováno v:
Stem Cell Research & Therapy, Vol 12, Iss 1, Pp 1-19 (2021)
Abstract Background Mobilization failure may occur when the conventional hematopoietic stem cells (HSCs) mobilization agent granulocyte colony-stimulating factor (G-CSF) is used alone, new regimens were developed to improve mobilization efficacy. Mul
Externí odkaz:
https://doaj.org/article/ce2a93733562408fbaacf882d5f796a0
Autor:
Teng Li, Chengxin Luo, Jiasi Zhang, Ling Wei, Wei Sun, Qin Xie, Yan Liu, Yongli Zhao, Shuangnian Xu, Lihua Wang
Publikováno v:
Stem Cell Research & Therapy, Vol 12, Iss 1, Pp 1-22 (2021)
Abstract Background Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is life-saving for severe hematological conditions. However, its outcomes need further improvement, and co-infusion of mesenchymal stem cells (MSCs) may show promise.
Externí odkaz:
https://doaj.org/article/203b59b44d6c4efaaf63afc21b340f68